Complete regression of bone metastases on super bone scan, by low-dose cisplatin, UFT, diethylstilbestrol diphosphate, and dexamethasone in a patient with hormone-refractory prostate cancer

Senji Hoshi, Chikara Ohyama, Shigeru Hagisawa, Kunio Ono, Makoto Satoh, Seiichi Saito, Atushi Fukuzaki, Yoichi Arai

Research output: Contribution to journalArticlepeer-review

11 Citations (Scopus)

Abstract

Many types of chemotherapy are now being attempted all over the world for hormone-refractory prostate cancer (HRPC) patients, and prostate-specific antigen (PSA) reduction in almost half of the treated patients has been reported. However, only a few studies have reported the response of bone metastasis. The authors report a patient with HRPC who obtained complete regression of bone metastases on super bone scan by biochemical modulation (BM), dexamethasone, and endocrine therapy.

Original languageEnglish
Pages (from-to)118-120
Number of pages3
JournalInternational Journal of Clinical Oncology
Volume8
Issue number2
DOIs
Publication statusPublished - 2003 Apr

Keywords

  • Biochemical modulation
  • Hormone-refractory prostate cancer
  • Regression
  • Super bone scan

ASJC Scopus subject areas

  • Surgery
  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'Complete regression of bone metastases on super bone scan, by low-dose cisplatin, UFT, diethylstilbestrol diphosphate, and dexamethasone in a patient with hormone-refractory prostate cancer'. Together they form a unique fingerprint.

Cite this